Loading stock data…
STE
$214.40-2.48 (-1.14%)
Market ClosedLast close May 1
STERIS plc provides infection prevention products and services worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
STERIS plc in the Healthcare sector is trading at $214.40. The stock is currently near its 52-week low of $209.98, remaining 11.6% below its 200-day moving average. Technical signals show neutral RSI of 37 and bearish MACD signal, explaining why STE maintains its current current market pressure. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 37) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$214.40
Potential Downside
36.4%
Whystock Fair Value$136.40
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus7 analysts
Buy
Mean target$279.29+30.3%
Range$231.00 – $300.00
Fundamentals
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assuran...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$21.94B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
31.14
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.07
Div Yield
Strong income play. Yield provides a meaningful total return floor.
110.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.04%
Volume
Today's trading volume
554,078
Recent News
1 Profitable Stock for Long-Term Investors and 2 We Brush Off
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
STERIS' Q4 2026 Earnings: What to Expect
STERIS will release its fourth-quarter earnings soon, and analysts anticipate a single-digit bottom-line growth.
Surgical Equipment & Consumables - Diversified Stocks Q4 Earnings: STERIS (NYSE:STE) Firing on All Cylinders
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at STERIS (NYSE:STE) and its peers.
Beta Bionics, Inc. (BBNX) Soars 10.3%: Is Further Upside Left in the Stock?
Beta Bionics, Inc. (BBNX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
A Look At STERIS (STE) Valuation After Recent Share Price Weakness And Long Term Gains
Why STERIS Stock Is on Investors’ Radar Today STERIS (STE) is back in focus after recent share price moves, with the stock showing mixed short term results that include a 1 day decline, a small 7 day gain, and a modest month return. See our latest analysis for STERIS. At a share price of US$223.75, STERIS has seen short term share price weakness, including a 90 day share price return of a 12.88% decline. However, longer term total shareholder returns, such as 4.08% over one year and 18.07%...